Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Feb 5, 2021

5250_rns_2021-02-05_44ad1050-912b-4be5-9434-135e86dddf9e.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 04 February 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,320,729 1.80% 610,144 0.47%
(2) Derivatives (other than options):
273,127 0.21% 441,267 0.34%
(3) Options and agreements to
purchase/sell: 6,000 0.00% 6,000 0.00%
TOTAL:
2,599,856 2.02% 1,057,411 0.82%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 207.6500 USD
Purchase 1 208.5000 USD
Purchase 1 207.4600 USD
Purchase 2 207.4650 USD
Purchase 2 207.0500 USD
Purchase 3 208.2333 USD
Purchase 4 207.9375 USD
Purchase 13 207.6415 USD
Purchase 100 207.4400 USD
Purchase 100 206.4000 USD
Purchase 100 206.6450 USD
Purchase 100 207.4200 USD
Purchase 100 206.0500 USD
Purchase 100 206.6550 USD
Purchase 100 206.2260 USD
Purchase 200 206.7900 USD
Purchase 200 206.7100 USD
Purchase 200 206.7000 USD
Purchase 200 206.6875 USD
Purchase 200 206.1300 USD
Purchase 237 207.0437 USD
Purchase 400 206.6537 USD
Purchase 500 208.0100 USD
Purchase 636 208.1378 USD
Purchase 2,514 209.2916 USD
Purchase 5,732 207.9438 USD
Purchase 6,232 207.9491 USD
Purchase 6,736 209.3000 USD
Purchase 7,891 208.5481 USD
Purchase 8,500 207.6261 USD
Purchase 9,619 208.9235 USD
Purchase 11,508 206.8556 USD
Sale 100 206.0700 USD
Sale 122 207.0306 USD
Sale 200 206.1300 USD
Sale 200 206.2260 USD
Sale 200 208.7500 USD
Sale 405 207.6553 USD
Sale 420 206.9463 USD
Sale 501 207.7433 USD
Sale 636 208.1378 USD
Sale 682 207.7406 USD
Sale 737 208.6092 USD
Sale 748 207.4023 USD
Sale 806 207.6652 USD
Sale 858 207.5810 USD
Sale 905 207.7710 USD
Sale 1,200 206.6758 USD
Sale 1,474 207.5547 USD
Sale 1,541 207.5472 USD
Sale 1,900 209.2991 USD
Sale 2,093 207.9934 USD
Sale 2,537 209.2767 USD
Sale 4,837 209.3000 USD
Sale 5,812 208.0215 USD
Sale 6,593 207.9846 USD
Sale 7,154 208.4625 USD
Sale 9,419 208.9874 USD
Sale 10,152 206.6275 USD

(b) Derivatives transactions (other than options transactions)

Product Name Nature of transaction Number of relevant securities Price per
unit
SWAP Long 121,000 209.3000 USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 5 Feb 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210205005246/en/

BARCLAYS PLC